Sign in

CIK 0001770069

  • Emerging growth company

MapLight Therapeutics, Inc.

Sign in to watch
Ticker
MPLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
832163243
Phone
+1 617-984-6300
Business address
800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Alvarado Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,256,232
in 7 filings, $193K under 10b5-1 plans

Net −$1,256,232. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-14 Catalyst4, Inc. 10% owner Purchase +4,400,000 $11.38 $50.1M 25,306,689
2026-08-14 Catalyst4, Inc. 10% owner Purchase · Warrants (right to buy) +2,928,686 $11.38 $33.3M 2,928,686
2026-07-30 Catalyst4, Inc. 10% owner Purchase +1,000,000 $13.00 $13.0M 20,906,689
2026-07-29 Catalyst4, Inc. 10% owner Purchase +3,000 $12.63 $38K 19,906,689
2026-07-28 Catalyst4, Inc. 10% owner Purchase +141,088 $10.74 $1.5M 19,838,552
2026-07-28 Catalyst4, Inc. 10% owner Purchase +65,137 $11.69 $761K 19,903,689
2025-10-28 Catalyst4, Inc. 10% owner Conversion +14,256,288 14,256,288
2025-10-28 Catalyst4, Inc. 10% owner Purchase +5,441,176 $17.00 $92.5M 19,697,464
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series A Preferred Stock −148,809 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series A-1 Preferred Stock −444,846 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series B Preferred Stock −1,263,768 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series B-1 Preferred Stock −275,148 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series C Preferred Stock −5,444,807 0
2025-10-28 Catalyst4, Inc. 10% owner Conversion · Series D Preferred Stock −6,678,910 0

Page 1 of 1 · 14 trades